In our analysis, 5-ASA usage significantly decreased from 39.6% in 2009 to 5.5% in 2020, reflecting a positive trend in narrowing the knowledge gap between Chinese providers and IBD consensus.
← all excerpts
Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease.
1
—
—